UK Biological Security Strategy
UK government strategy governing biosecurity funding and DNA-synthesis screening policy.
Last refreshed: 21 July 2026 · Appears in 1 active topic
Britain has a year to decide whether DNA-synthesis screening becomes law; what's at stake?
Timeline for UK Biological Security Strategy
Set out GBP 1.83bn in biosecurity centre funding
Pandemics and Biosecurity: Britain edges DNA screening into lawBackground
The strategy's latest implementation report, published 14 July, committed the UK Government to deciding within twelve months whether nucleic-acid synthesis screening should become statutory, currently a voluntary check among providers. The report also set out GBP 1.83bn for a network of national biosecurity centres, including GBP 1bn at Weybridge, GBP 580m at Dstl Porton Down and GBP 250m at Harwell, plus GBP 45m for engineering-biology risk management, and confirmed that Exercise Pegasus, described as the largest pandemic-scenario exercise in UK history, ran during the reporting year.
The strategy is the UK Government's governing framework for biosecurity funding and policy, spanning laboratory biosafety, DNA-synthesis screening, and pandemic preparedness exercises across departments and research sites.
The screening question echoes a parallel push in the United States, where the Biosecurity Modernization and Innovation Act (S.3741) would make DNA-synthesis screening mandatory for American providers after the heads of OpenAI, Anthropic and Google DeepMind warned Congress their own frontier models could lower the barrier to biological-weapons design.